{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:01:56Z","timestamp":1780383716177,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"EU E-RARE JTC grant \u201cPREPARE\u201d"},{"name":"Senior Clinical Researcher mandate of the Research Fund - Flanders"},{"name":"the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI), and the Heart and Stroke Foundation Chair in Cardiovascular Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41431-018-0206-3","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T07:56:12Z","timestamp":1529481372000},"page":"1623-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-7273","authenticated-orcid":false,"given":"Matthis","family":"Synofzik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Harmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranoot","family":"Tanpaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Palmaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bradley","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Gburek-Augustat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Z\u00fcchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Kr\u00e4geloh-Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Baets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R. Wayne","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-67","volume":"7","author":"L Huang","year":"2012","unstructured":"Huang L, Chardon JW, Carter MT, et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis. 2012;7:67.","journal-title":"Orphanet J Rare Dis"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"AS Allen","year":"2013","unstructured":"Epi KC, Epilepsy Phenome\/Genome P, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217\u201321.","journal-title":"Nature"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1007\/s00415-015-7705-8","volume":"262","author":"M Sasaki","year":"2015","unstructured":"Sasaki M, Ohba C, Iai M, et al. Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene. J Neurol. 2015;262:1278\u201384.","journal-title":"J Neurol"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/humu.22836","volume":"36","author":"M Gonzalez","year":"2015","unstructured":"Gonzalez M, Falk MJ, Gai X, Postrel R, Schule R, Zuchner S. Innovative genomic collaboration using the GENESIS (GEM.app) platform. Hum Mutat. 2015;36:950\u20136.","journal-title":"Hum Mutat"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevNeurobiol.v10.i1.20","volume":"10","author":"T Michikawa","year":"1996","unstructured":"Michikawa T, Miyawaki A, Furuichi T, Mikoshiba K. Inositol 1,4,5-trisphosphate receptors and calcium signaling. Crit Rev Neurobiol. 1996;10:39\u201355.","journal-title":"Crit Rev Neurobiol"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ajhg.2016.03.004","volume":"98","author":"S Gerber","year":"2016","unstructured":"Gerber S, Alzayady KJ, Burglen L, et al. Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome. Am J Hum Genet. 2016;98:971\u201380.","journal-title":"Am J Hum Genet"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ajhg.2016.03.018","volume":"98","author":"M McEntagart","year":"2016","unstructured":"McEntagart M, Williamson KA, Rainger JK, et al. A Restricted Repertoire of De Novo Mutations in ITPR1 Cause Gillespie Syndrome with Evidence for Dominant-Negative Effect. Am J Hum Genet. 2016;98:981\u201392.","journal-title":"Am J Hum Genet"},{"key":"206_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0486-z","volume":"11","author":"S Wente","year":"2016","unstructured":"Wente S, Schroder S, Buckard J, et al. Nosological delineation of congenital ocular motor apraxia type Cogan: an observational study. Orphanet J Rare Dis. 2016;11:104.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"206_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00415-016-8178-0","volume":"263","author":"Matthis Synofzik","year":"2016","unstructured":"Synofzik M, Fleszar Z, Schols L, et al. Identifying Niemann-Pick type C in early-onset ataxia: two quick clinical screening tools. J Neurol 2016;263:1911\u20138.","journal-title":"Journal of Neurology"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMra1006610","volume":"366","author":"M Anheim","year":"2012","unstructured":"Anheim M, Tranchant C, Koenig M. The autosomal recessive cerebellar ataxias. N Engl J Med. 2012;366:636\u201346.","journal-title":"N Engl J Med"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073\u201381.","journal-title":"Nat Protoc"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/epi.12201","volume":"54","author":"KR Veeramah","year":"2013","unstructured":"Veeramah KR, Johnstone L, Karafet TM, et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54:1270\u201381.","journal-title":"Epilepsia"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng.3239","volume":"47","author":"S Syrbe","year":"2015","unstructured":"Syrbe S, Hedrich UB, Riesch E, et al. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015;47:393\u20139.","journal-title":"Nat Genet"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/brain\/awx184","volume":"140","author":"S Masnada","year":"2017","unstructured":"Masnada S, Hedrich UBS, Gardella E, et al. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies. Brain. 2017;140:2337\u201354.","journal-title":"Brain"},{"key":"206_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0200-3","volume":"16","author":"K Smets","year":"2015","unstructured":"Smets K, Duarri A, Deconinck T, et al. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy. BMC Med Genet. 2015;16:51.","journal-title":"BMC Med Genet"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/379168a0","volume":"379","author":"M Matsumoto","year":"1996","unstructured":"Matsumoto M, Nakagawa T, Inoue T, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 1996;379:168\u201371.","journal-title":"Nature"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cge.12783","volume":"91","author":"S Barresi","year":"2017","unstructured":"Barresi S, Niceta M, Alfieri P, et al. Mutations in the IRBIT domain of ITPR1 are a frequent cause of autosomal dominant nonprogressive congenital ataxia. Clin Genet. 2017;91:86\u201391.","journal-title":"Clin Genet"},{"issue":"6","key":"206_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.pjnns.2017.06.012","volume":"51","author":"Joyutpal Das","year":"2017","unstructured":"Das J, Lilleker J, Shereef H, Ealing J. Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: description of an affected family and literature review. Neurol Neurochir Pol 2017;51:497-500.","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ajmg.a.37962","volume":"173","author":"T Dijk van","year":"2017","unstructured":"van Dijk T, Barth P, Reneman L, Appelhof B, Baas F, Poll-The BT. A de novo missense mutation in the inositol 1,4,5-triphosphate receptor type 1 gene causing severe pontine and cerebellar hypoplasia: expanding the phenotype of ITPR1-related spinocerebellar ataxia\u2019s. Am J Med Genet. 2017;173:207\u201312.","journal-title":"Am J Med Genet"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/brain\/awv117","volume":"138","author":"R Parolin Schnekenberg","year":"2015","unstructured":"Parolin Schnekenberg R, Perkins EM, Miller JW, et al. De novo point mutations in patients diagnosed with ataxic cerebral palsy. Brain. 2015;138:1817\u201332.","journal-title":"Brain"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1212\/01.wnl.0000311277.71046.a0","volume":"71","author":"K Hara","year":"2008","unstructured":"Hara K, Shiga A, Nozaki H, et al. Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families. Neurology. 2008;71:547\u201351.","journal-title":"Neurology"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0206-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:58:12Z","timestamp":1684616292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0206-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0206-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"9 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MS received consulting fees from Actelion Pharmaceuticals Ltd. KLH, EP and ST are employed by Ambry Genetics. IK-M received consulting fees from Actelion Pharmaceuticals Ltd. PB is Chief Operating Officer at Centogene AG, Rostock, since January 2016. This company has no direct market-related interests in this study and was not involved in any parts of this study. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}